| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 4,320 | $40 | $164.2K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 35,600 | $1 | $71.2K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 2,800 | $20 | $47.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 310 | $100 | $31.5K |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 920 | $30 | $30.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 90 | $150 | $13.8K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 10,500 | $1 | $10.5K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 140 | $70 | $9.5K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 140 | $60 | $8.4K |
| 99222 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 60 | $110 | $6.5K |